Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M LaVange

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Role of Statistics in Regulatory Decision MakingLisa M LaVange
Biometrics|June 9, 2021
Discussion on "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes" by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael RosenblumLisa M LaVange
Statistics in Medicine|December 19, 2015
A regulatory perspective on missing data in the aftermath of the NRC reportLisa M LaVange, Thomas Permutt
The New England Journal of Medicine|July 6, 2017
Master Protocols to Study Multiple Therapies, Multiple Diseases, or BothJanet Woodcock, Lisa M LaVange
Journal of Periodontology|August 19, 2007
Statistical projection of clinical subsample estimates to a survey populationLisa M LaVange, Gary G Koch
Journal of Periodontology|March 15, 2018
Statistical Projection of Clinical Subsample Estimates to a Survey PopulationLisa M LaVange, Gary G Koch
Circulation|December 6, 2006
Rank score testsLisa M LaVange, Gary G Koch
Statistics in Biopharmaceutical Research|January 2, 2025
Covariate-adaptive biased coin randomization for master protocols with multiple interventions and biomarker-stratified allocationTianhao Song, Lisa M LaVange, Anastasia Ivanova
Statistical Methods in Medical Research|June 23, 2005
Randomization-based nonparametric methods for the analysis of multicentre trialsLisa M LaVange, Todd A Durham, Gary G Koch
Pharmaceutical Statistics|August 6, 2013
Bayesian approach to the design and analysis of non-inferiority trials for anti-infective productsMeg A Gamalo, Ram C Tiwari, Lisa M LaVange
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Role of Statistics in Regulatory Decision MakingLisa M LaVange
Biometrics|June 9, 2021
Discussion on "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes" by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael RosenblumLisa M LaVange
Statistics in Medicine|December 19, 2015
A regulatory perspective on missing data in the aftermath of the NRC reportLisa M LaVange, Thomas Permutt
The New England Journal of Medicine|July 6, 2017
Master Protocols to Study Multiple Therapies, Multiple Diseases, or BothJanet Woodcock, Lisa M LaVange
Journal of Periodontology|August 19, 2007
Statistical projection of clinical subsample estimates to a survey populationLisa M LaVange, Gary G Koch
Journal of Periodontology|March 15, 2018
Statistical Projection of Clinical Subsample Estimates to a Survey PopulationLisa M LaVange, Gary G Koch
Circulation|December 6, 2006
Rank score testsLisa M LaVange, Gary G Koch
Statistics in Biopharmaceutical Research|January 2, 2025
Covariate-adaptive biased coin randomization for master protocols with multiple interventions and biomarker-stratified allocationTianhao Song, Lisa M LaVange, Anastasia Ivanova
Statistical Methods in Medical Research|June 23, 2005
Randomization-based nonparametric methods for the analysis of multicentre trialsLisa M LaVange, Todd A Durham, Gary G Koch
Pharmaceutical Statistics|August 6, 2013
Bayesian approach to the design and analysis of non-inferiority trials for anti-infective productsMeg A Gamalo, Ram C Tiwari, Lisa M LaVange
Pageof 4